se of atorvastatin in bone marrow transplantatio

Phase 2

• Conditions: Condition 1: Follicular lymphoma. Condition 2: Hodgkin lymphoma. Condition 3: Non-follicular lymphoma. Condition 4: Multiple myeloma and malignant plasma cell neoplasms.; Follicular lymphoma; Hodgkin lymphoma; Non-follicular lymphoma; Multiple myeloma and malignant plasma cell neoplasms

• Registration Number: IRCT2014071418484N1
• Lead Sponsor: Vice Chancellor for Research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Major inclusion criteria:
Age equals to or greater than 18; Primary diagnosis consist of Hodgkin's lymphoma, Non-Hodgkin's lymphoma or Multiple Myeloma; Patient endorsement of informed consent

Major exclusion criteria:
Patients taking any statin drug at the time of enrollment; Occurrence of suspected drug related toxicity during treatment

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean number of hematopoietic progenitor cells per microliter of peripheral blood. Timepoint: Baseline, at the time of cell harvest. Method of measurement: Number of cells by flowcytometry assessment.